Fitzpatrick Alexander A
SEC insider (Form 3/4/5 filer). CIK 0001398595. Chief Legal Officer at ARS Pharmaceuticals, Inc. (SPRY). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in SAN DIEGO, CA.
Companies Fitzpatrick Alexander A has filed insider reports for
- ARS Pharmaceuticals, Inc. (SPRY): Officer, Chief Legal Officer
Fitzpatrick Alexander A
CIK: 0001398595
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARS Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 12, 2026SPRY
ARS Pharmaceuticals, Inc.
SaleDirect3.4K shares at avg. $10.00$34K - Jan 2, 2026SPRY
ARS Pharmaceuticals, Inc.
AwardDirectStock option (right to buy)
240K shares- - May 20, 2025SPRY
ARS Pharmaceuticals, Inc.
ExerciseDirect100K shares at avg. $5.58$558K - May 20, 2025SPRY
ARS Pharmaceuticals, Inc.
SaleDirect103K shares at avg. $14.10$1.5M - Jan 2, 2025SPRY
ARS Pharmaceuticals, Inc.
AwardDirectStock option (right to buy)
152.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 | SPRY ARS Pharmaceuticals, Inc. | Sale | 3,355 | $10.00 | $33,550 | Direct |
| Jan 2, 2026 | SPRY ARS Pharmaceuticals, Inc. | Award Stock option (right to buy) | 240,000 | - | - | Direct |
| May 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | Exercise | 100,000 | $5.58 | $558,000 | Direct |
| May 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | Sale | 102,969 | $14.10 | $1,451,513 | Direct |
| Jan 2, 2025 | SPRY ARS Pharmaceuticals, Inc. | Award Stock option (right to buy) | 152,300 | - | - | Direct |
1-5 of 5 transactions